tradingkey.logo
搜尋

Sanara Medtech Inc

SMTI
添加自選
33.860USD
-0.200-0.59%
收盤 07-31 16:00美東報價延遲15分鐘
311.28M總市值
虧損本益比TTM

關於 Sanara Medtech Inc 公司

Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.

Sanara Medtech Inc簡介

公司代碼SMTI
公司名稱Sanara Medtech Inc
上市日期Apr 07, 1994
CEOMuppalla (Suresh V)
員工數量141
證券類型Ordinary Share
年結日Apr 07
公司地址1200 Summit Avenue
城市FORT WORTH
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編76102
電話18175292300
網址https://sanaramedtech.com/
公司代碼SMTI
上市日期Apr 07, 1994
CEOMuppalla (Suresh V)

Sanara Medtech Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.55K
-3.52%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
25.41K
+18.16%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
22.97K
+23.11%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
14.23K
+34.05%
Mr. Keith G. Myers
Mr. Keith G. Myers
Independent Director
Independent Director
9.32K
+47.02%
Mr. Suresh V. (Sam) Muppalla
Mr. Suresh V. (Sam) Muppalla
President and Chief Executive Officer of Tissue Health Plus, LLC
President and Chief Executive Officer of Tissue Health Plus, LLC
2.97K
--
Mr. Robert A. (Bob) DeSutter
Mr. Robert A. (Bob) DeSutter
Independent Director
Independent Director
--
--
Mr. Roszell Mack, III
Mr. Roszell Mack, III
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.55K
-3.52%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
25.41K
+18.16%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
22.97K
+23.11%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
14.23K
+34.05%

常見問題

Sanara Medtech Inc的前五大股東是誰?

Sanara Medtech Inc的前五大股東如下:Mr. Seth D. Yon

有多少機構持有Sanara Medtech Inc(SMTI)的股份?

截至2026Q1,共有131家機構持有Sanara Medtech Inc的股份,合計持有的股份價值約為1.42M,占公司總股份的15.50% 。與2025Q4相比,機構持股有所增加,增幅為-599767.00。

哪個業務部門對Sanara Medtech Inc的收入貢獻最大?

在2026Q1,Soft tissue repair products業務部門對Sanara Medtech Inc的收入貢獻最大,創收91.35M,占總收入的88.59% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有